BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1909945)

  • 1. Changes in carbohydrate metabolism during 30 months on Norplant.
    Konje JC; Otolorin EO; Ladipo OA
    Contraception; 1991 Aug; 44(2):163-72. PubMed ID: 1909945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbohydrate metabolism before and after Norplant removal.
    Konje JC; Odukoya OA; Otolorin EO; Ewings PD; Ladipo OA
    Contraception; 1992 Jul; 46(1):61-9. PubMed ID: 1424624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin sensitivity is unaltered by the use of the Norplant subdermal implant contraceptive.
    Koopersmith TB; Lobo RA
    Contraception; 1995 Mar; 51(3):197-200. PubMed ID: 7621688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Norplant contraceptive subdermal implants on serum lipids and lipoproteins.
    Otubu JA; Towobola OA; Aisien AO; Ogunkeye OO
    Contraception; 1993 Feb; 47(2):149-59. PubMed ID: 8449015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of D-norgestrel, 30 micrograms, on the oral glucose tolerance test, including insulin levels, in Thai women.
    Vongvinyoutragan S; Matangkasombut O; Poshyachinda V; Dusitsin N; Tankeyoon M; Israngkun P; Chaudhury RR
    Fertil Steril; 1976 May; 27(5):523-7. PubMed ID: 1278455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
    Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
    Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile.
    Fahmy K; Abdel-Razik M; Shaaraway M; al-Kholy G; Saad S; Wagdi A; al-Azzony M
    Contraception; 1991 Oct; 44(4):419-30. PubMed ID: 1836754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of the metabolic effects of injectable and oral contraceptives.
    Liew DF; Ng CS; Heng SH; Ratnam SS
    Contraception; 1986 Apr; 33(4):385-94. PubMed ID: 2942334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of Norplant on clinical chemistry in Singaporean acceptors after 1 year of use: metabolic changes.
    Viegas OA; Singh K; Liew D; Singh P; Ratnam SS
    Contraception; 1988 Jul; 38(1):79-89. PubMed ID: 3139359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of levonorgestrel contraceptive implants, NORPLANT, initiated early postpartum upon lactation and infant growth.
    Shaaban MM; Salem HT; Abdullah KA
    Contraception; 1985 Dec; 32(6):623-35. PubMed ID: 3937665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of continuous subdermal levonorgestrel (Norplant) on carbohydrate metabolism.
    Konje JC; Otolorin EO; Ladipo OA
    Am J Obstet Gynecol; 1992 Jan; 166(1 Pt 1):15-9. PubMed ID: 1733189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Norplant implants on liver, lipid and carbohydrate metabolism.
    Singh K; Viegas OA; Loke DF; Ratnam SS
    Contraception; 1992 Feb; 45(2):141-53. PubMed ID: 1559336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insertion site complications during the first year of NORPLANT use.
    Klavon SL; Grubb GS
    Contraception; 1990 Jan; 41(1):27-37. PubMed ID: 2105871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
    Kamal I; Zaki K; Rashad S
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of Norplant on glucose metabolism under hyperglycemic hyperinsulinemic conditions.
    Shamma FN; Rossi G; HajHassan L; Penzias AS; Connoly-Diamond M; Jones E; Diamond MP
    Fertil Steril; 1995 Apr; 63(4):767-72. PubMed ID: 7890060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of daily 30 MCG norgestrel on glucose, insulin, cholesterol and triglycerides during 1 year's time of use.
    Boonsiri B; Virutamasen P; Tangkeo P; Wongsrichanalai C
    Asia Oceania J Obstet Gynaecol; 1983 Jun; 9(2):180-4. PubMed ID: 6351820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective studies of carbohydrate metabolism in "normal" women using norgestrel for eighteen months.
    Spellacy WN; Buhi WC; Birk SA
    Fertil Steril; 1981 Feb; 35(2):167-71. PubMed ID: 7009219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of continuous levonorgestrel treatment (subcutaneous capsules) on the lipoprotein and carbohydrate metabolism in fertile women.
    Lithell H; Weiner E; Vessby B; Johansson ED
    Ups J Med Sci; 1983; 88(2):103-8. PubMed ID: 6417867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian endocrine function through five years of continuous treatment with NORPLANT subdermal contraceptive implants.
    Brache V; Alvarez-Sanchez F; Faundes A; Tejada AS; Cochon L
    Contraception; 1990 Feb; 41(2):169-77. PubMed ID: 2107058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.